Exact Sciences (EXAS) grants SVP Herriott 20,321 restricted stock units

Q: How many restricted stock units were granted to James Herriott at Exact Sciences (EXAS)?

James Herriott was granted 20,321 restricted stock units . Each unit represents a contingent right to receive one share of Exact Sciences common stock, reflecting stock-based compensation rather than a cash purchase on the grant date.

Q: What is the vesting schedule for James Herriott’s new RSUs at Exact Sciences (EXAS)?

The 20,321 restricted stock units vest in four equal annual installments . Vesting begins on February 25, 2027 , meaning one-quarter of the award will vest on that date and annually thereafter, subject to applicable award terms.

Q: How many Exact Sciences (EXAS) common shares does James Herriott hold after this transaction?

After the reported transactions, James Herriott holds 69,577 shares of Exact Sciences common stock . This total includes both shares held directly and shares held indirectly in a 401(k) plan associated with him.

Q: Does the Form 4 show any Exact Sciences (EXAS) stock sales by James Herriott?

The filing reports an acquisition of restricted stock units , not open-market stock sales. It lists his resulting holdings in common shares and additional options and RSUs, without disclosing any sale transactions in this report.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Herriott James reported acquisition or exercise transactions in this Form 4 filing.

Exact Sciences Corp reported that SVP, General Counsel & Secretary James Herriott received a grant of 20,321 restricted stock units (RSUs) on February 25, 2026. Each RSU represents a contingent right to receive one share of common stock and carries no purchase price.

These RSUs vest in four equal annual installments beginning on February 25, 2027. After this award, Herriott holds a total of 69,577 shares of common stock (including shares held directly and in a 401(k) plan), and in addition holds an aggregate of 23,975 vested and unvested options and restricted stock units tied to Exact Sciences common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Herriott James

Role SVP, General Counsel & Sec

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	20,321	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 20,321 shares (Direct); Common Stock — 67,815 shares (Direct); Common Stock — 1,762 shares (Indirect, Held in 401(k) Plan)

Footnotes (1)

In addition to the shares of Common Stock reported on this Form 4, which total 69,577 shares, Mr. Herriott also holds, in the aggregate, an additional 23,975 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

02/27/2026 - 04:30 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herriott James

(Last)

(First)

(Middle)

C/O EXACT SCIENCES CORP.

5505 ENDEAVOR LANE

(Street)

MADISON

53719

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
EXACT SCIENCES CORP [ EXAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, General Counsel & Sec

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								67,815⁽¹⁾	D
Common Stock								1,762	I	Held in 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	02/25/2026		A		20,321		⁽³⁾	⁽³⁾	Common Stock	20,321	$0	20,321	D

Explanation of Responses:

1. In addition to the shares of Common Stock reported on this Form 4, which total 69,577 shares, Mr. Herriott also holds, in the aggregate, an additional 23,975 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

2. Each restricted stock unit represents a contingent right to receive one share of common stock.

3. These restricted stock units vest in four equal annual installments beginning on February 25, 2027.

	/s/ James Herriott by Mark Busch, attorney-in- fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Exact Sciences (EXAS) disclose in this Form 4 filing?

Exact Sciences reported a stock-based compensation award to executive James Herriott. He received restricted stock units and now holds common shares plus additional options and RSUs tied to Exact Sciences common stock.

How many restricted stock units were granted to James Herriott at Exact Sciences (EXAS)?

James Herriott was granted 20,321 restricted stock units. Each unit represents a contingent right to receive one share of Exact Sciences common stock, reflecting stock-based compensation rather than a cash purchase on the grant date.

What is the vesting schedule for James Herriott’s new RSUs at Exact Sciences (EXAS)?

The 20,321 restricted stock units vest in four equal annual installments. Vesting begins on February 25, 2027, meaning one-quarter of the award will vest on that date and annually thereafter, subject to applicable award terms.

How many Exact Sciences (EXAS) common shares does James Herriott hold after this transaction?

After the reported transactions, James Herriott holds 69,577 shares of Exact Sciences common stock. This total includes both shares held directly and shares held indirectly in a 401(k) plan associated with him.

What additional equity awards does James Herriott hold in Exact Sciences (EXAS)?

Besides his common shares, James Herriott holds an aggregate of 23,975 vested and unvested options and restricted stock units. Each restricted stock unit corresponds to a contingent right to receive one share of Exact Sciences common stock.

Does the Form 4 show any Exact Sciences (EXAS) stock sales by James Herriott?

The filing reports an acquisition of restricted stock units, not open-market stock sales. It lists his resulting holdings in common shares and additional options and RSUs, without disclosing any sale transactions in this report.